Wird geladen...
Endophthalmitis rates among patients receiving intravitreal anti-VEGF injections: a USA claims analysis
PURPOSE: Intravitreal (IVT) injections of the anti-vascular endothelial growth factor (VEGF) agents aflibercept, bevacizumab, and ranibizumab are commonly prescribed to treat neovascular age-related macular degeneration (nAMD). Studies comparing inflammation rates in large populations of patients re...
Gespeichert in:
| Veröffentlicht in: | Clin Ophthalmol |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove Medical Press
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6124467/ https://ncbi.nlm.nih.gov/pubmed/30214147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S169143 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|